[1] |
LIU Xiumei, GUO Qianqian, FANG Yuan, CHEN Nan, QI Qi.
Pharmaceutical care of patients with antithrombotic therapy after transjugular intrahepatic portal shunt
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 556-560.
|
[2] |
WU Yuanzhu, LIU Jun, YANG Kui, PENG Jing, LUAN Jiajie, WEI Jun, ZHANG Dafa, SONG Shuai, YUAN Xiaolong, WANG Zhongfang, ZHANG Nianbao, XIE Dan, JIANG Peng, FAN Jie.
Distribution of CYP2C9*3 and VKORC1-1639G>A gene polymorphism in Anhui Han population and their influence on the stable dose of warfarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 652-659.
|
[3] |
LIAN Jinfang, LIU Yiwei, LIN Cuihong, HUANG Pinfang, LIN Rongfang.
Comparison of prediction accuracy between warfarin PPK/PD model and multiple regression dose models
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 267-273.
|
[4] |
WEN Dusu, WANG Yi, SUN Jianjun.
Comparison of Bayesian method and multiple linear regression method in predicting warfarin dose model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 33-38.
|
[5] |
ZHANG Ningyuan, ZHENG Xijun, XU Ling, LIU Hongxia, ZHENG Qingshan.
Disease progression model for Alzheimer's disease and its research progress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 687-694.
|
[6] |
JIAO Zheng, LI Xingang, SHANG Dewei, DONG Jing, ZUO Xiaocong, CHEN Bing, LIU Jianmin, PAN Yan, ZHOU Tianyan, ZHANG Jing, LIU Dongyang, LI Lujin, FANG Yi, MA Guangli, DING Junjie, ZHAO Wei, CHEN Rui, XIANG Xiaoqiang, WANG Yuzhu, GAO Jianjun, XIE Haitang, HU Pei, ZHENG Qingshan.
Model informed precision dosing: China expert consensus report
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(11): 1215-1228.
|
[7] |
ZHAI Yu, YANG Jin.
Effects of dietary vitamin K on the stability of warfarin anticoagulation therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 709-715.
|
[8] |
LI Jian, YANG Jinbo, WANG Yuzhu.
Discussion on the format and content of new drug population pharmacokinetic study report
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 546-549.
|
[9] |
LI Lujin, DING Junjie, LIU Dongyang, WANG Xipei, DENG Chenhui, JI Shangmin, CHEN Wenjun, MA Guangli, WANG Kun, SHENG Yucheng, XU Ling, PEI Qi, CHEN Yuancheng, CHEN Rui, SHI Jun, LI Gailing, WANG Yaning, WANG Yuzhu, XIE Haitang, ZHOU Tianyan, FANG Yi, ZHANG Jing, JIAO Zheng, HU Bei, ZHENG Qingshan.
General considerations of model-based meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1250-1267.
|
[10] |
MA Guangli, XU Ling, CHEN Rui, CHEN Yuancheng, ZHAO Wei, LIU Dongyang, JIAO Zheng, LI Jian, JI Shuangmin, LI Li, LI Liang, WANG Yuzhu, YANG Jinbo, WANG Yaning, SUN He, HU Pei, ZHENG Qingshan, LU Wei.
General considerations of population pharmacokinetic/pharmacodynamic study in new drug development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1201-1220.
|
[11] |
ZHANG Huimin, LIU Aiming, ZHU Wenfeng, YU Lingzhi, CHEN Fangliang.
Scientific decision process and regulation requirements based on the current guidelines of data extrapolation from adult to pediatric population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(1): 49-56.
|
[12] |
LIU Dongyang,WANG Kun,MA Guangli,XIANG Xiaoqiang,LIU Jiang,ZHAO Ping,CHEN Rui,CHEN Yuancheng,HUANG Xiaohui, LI Li,LI Lujin,NIE Jing,WANG Yuzhu,WEI Chunmin,LU Wei,SHI Jun, ZHENG Qingshan.
The value and general consideration of pharmacometric study in new drug development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 961-973.
|
[13] |
JI Shuangmin, ZHU Xiao, GAO Liucun, YANG Huan, GAO Chenyan.
Research advances on target-mediated drug disposition(TMDD) models
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 481-487.
|
[14] |
WANG Shiqi, HU Huawen, CHEN Xiaomin, WANG Jian, YE Honghua.
Effects of different intensities of warfarin on patients with coronary atherosclerotic heart disease complicated with atrial fibrillation: a comparative study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1410-1414.
|
[15] |
YANG Rui, XU Haisha, ZHANG Zanling, QU Jian, LI Juan, PENG Shiqi, DAI Yuxin, QU Qiang.
Effect of drug interaction on anticoagulant strength of warfarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1426-1431.
|